Suleman Alihodzic

Title: Suleman Alihodzic: Innovator in Macrolide Antibiotics

Introduction

Suleman Alihodzic is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolide antibiotics. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Alihodzic's latest patents focus on novel semi-synthetic macrolides. The first patent describes derivatives of 8a-aza-8a-homoerythromycin A, which exhibit antibacterial activity. This invention includes processes for their preparation, compositions containing them, and their applications in medicine. The second patent relates to 14 or 15 membered macrolides that are substituted at the 4' position. This patent also covers pharmaceutically acceptable salts and solvates, along with processes for their preparation and their therapeutic use against systemic or topical bacterial infections in humans or animals.

Career Highlights

Throughout his career, Alihodzic has worked with prominent companies in the pharmaceutical industry. He has been associated with Glaxo Group Limited and GlaxoSmithKline Istraživački Centar Zagreb d.o.o. These experiences have provided him with a solid foundation in research and development, allowing him to innovate in the field of antibiotics.

Collaborations

Some of his notable coworkers include Andrea Berdik and Antun Hutinec. Their collaboration has likely contributed to the advancements in the projects they have worked on together.

Conclusion

Suleman Alihodzic is a distinguished inventor whose work in macrolide antibiotics showcases his commitment to advancing medical science. His patents reflect innovative approaches to combating bacterial infections, highlighting his valuable contributions to the pharmaceutical industry.